Global Human Leukocyte Antigen (HLA) Typing for Transplant Market Segmentation, By Products and Services (Reagents and Consumables, Instruments, Software and Services), Technology (Molecular Assay Technologies, Non- Molecular Assay Technologies), Transplant Type (Solid Organ Transplant, Hematopoietic Stem Cell Transplant), Application (Diagnostic Applications, Research Application), End User (Independent Reference Laboratories, Hospitals and Transplant Centers, Research Laboratories and Academic Institutes) – Industry Trends and Forecast to 2031.
Human Leukocyte Antigen (HLA) Typing for Transplant Market Analysis
There has been rapid growth in the demand for transplantation procedures due to certain diseases such as blood cancers, and genetic blood disorders where stem cell transplantation is required. Over the years, the increased public awareness about organ transplantation coupled with regulatory authorities' supporting regulation have accelerated the market forward. With constantly increasing transplant procedures worldwide, the market is projected to show substantial growth over the forecasted period.
Human Leukocyte Antigen (HLA) Typing for Transplant Market Size
Global human leukocyte antigen (HLA) typing for transplant market size was valued at USD 914.42 million in 2023 and is projected to reach USD 1743.33 million by 2031, with a CAGR of 8.4% during the forecast period of 2024 to 2031.
Report Scope and Market Segmentation
|
Attributes
|
Human Leukocyte Antigen (HLA) Typing for Transplant Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa
|
|
Key Market Players
|
Thermo Fisher Scientific (U.S), QIAGEN (Netherlands), Illumina (US), CareDx, (US), Immucor, (U.S), Bio-Rad Laboratories, Inc. (U.S), F. Hoffman-La Roche Ltd. (Switzerland), Hologic, Inc. (U.S), Luminex Corporation (U.S), Biofortuna (UK), Bruker (US), Abbott (US), Takara Bio Inc.,(Japan), Omixon Inc., (Hungary), Siemens (Germany), EKF Diagnostics (UK), BD (US), Fujirebio, (Japan), and TBG Diagnostics Limited (Australia)
|
Human Leukocyte Antigen (HLA) Typing for Transplant Market Definition
Human leukocyte antigen (HLA) typing determines if patients and donors are compatible for cord blood or bone marrow transplants. Human leukocyte antigens (HLA) are proteins found in our bodies. The human immune system uses these markers to determine which cells belong in your body and which cells are foreign.
Human Leukocyte Antigen (HLA) Typing for Transplant Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
Drivers
- Increasing Transplant Procedures
The growing burden of infectious diseases coupled with the increasing number of transplant procedures, is the most significant factor driving the growth for this market. Growing donation procedure for transplantation is also expected to accelerate the market's overall growth.
Furthermore, the major market players are highly focusing on product launches and product approvals along with the government and regulatory bodies, who are supporting market players by virtue of product approval are also expected to fuel market growth within the forecasted period.
Restraints/Challenges Global Human Leukocyte Antigen (HLA) Typing for Transplant Market
- High Costs
The high costs associated with NGS and PCR systems and equipment are very costly. The high cost of these equipment and systems will further create affordability issues, which is expected to obstruct market growth.
The unfavorable reimbursement policies regarding organ transplant restraint the growth of the market. Moreover, the market is facing a huge hurdle in terms of growth due to the low number of donors compared to donor accepters.
Opportunities
- Rising Advancements and Research Activities Will Provide Opportunities
The increasing public-private funding for target research activities are also projected to offer various growth opportunities for the market. Moreover, the technological advancements in the field of transplant diagnostics are estimated to generate lucrative opportunities for the market. Various technological advancements and the rapid shift from serological assays to gene-based HLA typing will further expand the human leukocyte antigen (HLA) typing for transplant market's growth rate in the future.
This human leukocyte antigen (HLA) typing for transplant market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the human leukocyte antigen (HLA) typing for transplant market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Post Covid-19 Impact on Human Leukocyte Antigen (HLA) Typing for Transplant Market
The outbreak of COVID-19 is projected to have a substantial impact on the human leukocyte antigen (HLA) typing for transplant market. Pharmaceutical and biotech companies, in collaboration with governments throughout the world, are working to combat the COVID-19 outbreak, from vaccine research to planning for obstacles in the pharmaceutical supply chain. Various vaccine candidates and compounds are currently being developed in the research and development pipeline. Furthermore, there was a high adoption of Hydroxychloroquine to curb COVID-19. Owing to the immense demand for these treatments, manufacturers of COVID-19 management drugs have a lot of prospects, as many wealthy countries are running out of them.
Moreover, the pharmaceutical and biotechnology industries are predicted to increase significantly due to the demand for COVID-19 vaccines and treatment medications.
Human leukocyte antigen (HLA) Typing for Transplant Market Scope
The human leukocyte antigen (HLA) typing for transplant market is segmented on the basis of products and services, technology, transplant type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Products and Services
- Reagents and Consumables
- Instruments
- Software and Services
On the basis of products and services, the human leukocyte antigen (HLA) typing for transplant market is segmented into reagents and consumables, instruments and software and services.
Technology
- Molecular Assay Technologies
- Non- Molecular Assay Technologies
On the basis of technology, the human leukocyte antigen (HLA) typing for transplant market is segmented into molecular assay technologies and non- molecular assay technologies. Molecular assay technologies are sub-segmented into PCR-based molecular assays and sequencing-based molecular assays. PCR-based molecular assays are further sub-segmented into Real-time PCR, sequence-specific primer-PCR, sequence-specific oligonucleotide-PCR and other PCR-based molecular assays. The sequencing-based molecular assays are further sub-segmented into sanger sequencing, next-generation sequencing and other sequencing-based molecular assays. The molecular assay technologies accounts for the largest share of the market because of benefits offered by molecular assays such as high procedural efficacy, low turnaround time, the study of multiple samples and real-time sample analysis.
Transplant Type
- Solid Organ Transplant
- Hematopoietic Stem Cell Transplant
On the basis of transplant type, the human leukocyte antigen (HLA) typing for transplant market is segmented into solid organ transplant and hematopoietic stem cell transplant.
Application
- Diagnostic Applications
- Research Application
On the basis of application, the human leukocyte antigen (HLA) typing for transplant market is segmented into diagnostic applications and research application.
End User
- Independent Reference Laboratories
- Hospitals and Transplant Centres
- Research Laboratories and Academic Institutes
On the basis of end user, the human leukocyte antigen (HLA) typing for transplant market is bifurcated into independent reference laboratories, hospitals and transplant centers, research laboratories and academic institutes.
Human Leukocyte Antigen (HLA) Typing for Transplant Market Regional Analysis
The human leukocyte antigen (HLA) typing for transplant market is analyzed and market size insights and trends are provided by country, products and services, technology, transplant type, application and end user as referenced above.
The countries covered in the human leukocyte antigen (HLA) typing for transplant market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the human leukocyte antigen (HLA) typing for transplant market because of the technological advancements in the field of transplant diagnostics and the large volume of organ transplantation procedures performed within the region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the rising awareness about donations and supportive regulations by the government within the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The human leukocyte antigen (HLA) typing for transplant market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for human leukocyte antigen (HLA) typing for transplant market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the human leukocyte antigen (HLA) typing for transplant market. The data is available for historic period 2010-2020.
Human Leukocyte Antigen (HLA) Typing For Transplant Market Share
The human leukocyte antigen (HLA) typing for transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to human leukocyte antigen (HLA) typing for transplant market.
Human Leukocyte Antigen (HLA) Typing For Transplant Market Leaders Operating in the Market Are:
- Thermo Fisher Scientific (U.S)
- QIAGEN (Netherlands)
- Illumina (US)
- CareDx, (US)
- Immucor, (U.S)
- Bio-Rad Laboratories, Inc. (U.S)
- F. Hoffman-La Roche Ltd. (Switzerland)
- Hologic, Inc. (U.S)
- Luminex Corporation (U.S)
- Biofortuna (UK)
- Bruker (US)
- Abbott (US)
- Takara Bio Inc.,(Japan)
- Omixon Inc., (Hungary)
- Siemens (Germany)
- EKF Diagnostics (UK)
- BD (US)
- Fujirebio, (Japan)
- TBG Diagnostics Limited (Australia)
Latest Developments in Human Leukocyte Antigen (HLA) Typing For Transplant Market
- In January 2020, Genome Diagnostics B.V. ("GenDx") announced a partnership with Berlin-based PIRCHE AG and the release of a new edition of their NGSengine® software. NGSengine, widely regarded as the ultimate Human Leukocyte Antigen (HLA) typing programme for numerous NGS systems, can now export individual sample HLA typing data to the PIRCHE matching services website.
SKU-